ctrl K

Price Alert

Recursion Pharmaceuticals... (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

5.74

0.10 (1.77%)

At close: Aug 15, 2025, 12:41 PM

Recursion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	594.35M	391.56M	549.91M	285.12M
Short-Term Investments	n/a	n/a	n/a	231.45M
Long-Term Investments	n/a	n/a	7.92M	8.68M
Other Long-Term Assets	14.45M	6.89M	7.92M	8.72M
Receivables	49.17M	3.09M	2.75M	9.09M
Inventory	n/a	n/a	1.28M	1.55M
Other Current Assets	70.75M	43.48M	17.15M	9.07M
Total Current Assets	714.27M	438.14M	569.81M	534.72M
Property-Plant & Equipment	233.21M	120.17M	121.45M	64.72M
Goodwill & Intangibles	484.73M	88.5M	2.11M	2.19M
Total Long-Term Assets	734.33M	215.56M	131.47M	75.63M
Total Assets	1.45B	653.7M	701.29M	610.35M
Account Payables	21.61M	3.95M	4.59M	2.82M
Deferred Revenue	61.77M	36.43M	56.73M	10M
Short-Term Debt	22.22M	41K	6.05M	1.51M
Other Current Liabilities	81.87M	23.75M	14.48M	20.59M
Total Current Liabilities	187.47M	93.17M	100.27M	46.66M
Long-Term Debt	19.02M	1.1M	536K	633K
Other Long-Term Liabilities	190.75M	n/a	n/a	4.11M
Total Long-Term Liabilities	226.34M	97.09M	115.22M	20.75M
Total Liabilities	413.82M	190.26M	215.48M	67.41M
Total Debt	108.49M	50.67M	51.01M	11.48M
Common Stock	4K	2K	2K	2K
Retained Earnings	-1.43B	-967.62M	-639.56M	-400.08M
Comprehensive Income	-7.64M	-0.00	0.00	-126K
Shareholders Equity	1.03B	463.44M	485.81M	542.94M
Total Investments	n/a	6.63M	7.92M	231.45M